Tag: #Tolvaptan
-
Successful Long-Term Tolvaptan Therapy in a Patient with Enlarged Polycystic Kidneys A Case Study
Introduction Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a progressive condition characterized by the enlargement of cystic kidneys and declining renal function. Tolvaptan, a vasopressin V2 receptor antagonist, is widely used to slow this progression. This case study examines an ADPKD patient with significantly enlarged kidneys who responded positively to long-term Tolvaptan therapy. Visit HSPIOA…
-
Long-Term Efficacy of Tolvaptan in Managing Enlarged Polycystic Kidneys A Case Study
Introduction Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a progressive condition characterized by kidney enlargement and declining renal function. A recent case study highlights the long-term efficacy of tolvaptan, a vasopressin V2 receptor antagonist, in stabilizing kidney size and function in a patient with markedly enlarged polycystic kidneys. Visit HSPIOA for more groundbreaking research in…
Heighten Science Publications Inc. 